Dexamethasone 1 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension — RxCUI 309683
RxNorm drug concept · Semantic clinical drug
RxCUI 309683
Semantic clinical drug · SCD
● Current RxNorm concept 24 FDA products
32 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI309683
Official nameDexamethasone 1 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdexamethasone 0.1 % / tobramycin 0.3 % Ophthalmic Suspension
FDA products mapped24
Package NDCs mapped32
Reported Medicaid activity (SDUD)119,376 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dexamethasone Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- You're right — it does treat a wide range of conditions, and that can feel a bit overwhelming. Basically, dexamethasone is a powerful anti-inflammatory medication that works across...
- What is dexamethasone injection actually used for? It seems like it treats a lot of different things.
- Yes, that's an important one. Dexamethasone does suppress the immune system, which means your body has a harder time fighting off infections while you're on it. It can also make ex...
- Will this injection affect my immune system? Should I avoid sick people?
🕸️ Concept Web — How Dexamethasone 1 MG/ML / tobramycin 3 MG/ML Ophth... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dexamethasone 1 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension
RxCUI 309683 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Dexamethasone
3264IN -
Tobramycin
10627IN -
Dexamethasone / tobramycin
883815MIN
-
Dexamethasone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Tobradex
220330BN
-
Tobradex
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dexamethasone / tobramycin Ophthalmic Suspension
378984SCDF -
Dexamethasone / tobramycin Ophthalmic Product
1154524SCDG -
Dexamethasone / tobramycin Ophthalmic Suspension [Tobradex]
94334SBDF -
Tobradex Ophthalmic Product
1179099SBDG -
Ophthalmic Suspension
316964DF -
Ophthalmic Product
1151135DFG
-
Dexamethasone / tobramycin Ophthalmic Suspension
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dexamethasone 1 MG/ML
317629SCDC -
Tobramycin 3 MG/ML
323975SCDC -
Dexamethasone 1 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension [Tobradex]
208813SBD -
Dexamethasone 1 MG/ML / tobramycin 3 MG/ML [Tobradex]
569462SBDC
-
Dexamethasone 1 MG/ML
Showing up to 8 concepts per family — 14 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dexamethasone 1 MG/ML
SCDC · 317629 -
Tobramycin 3 MG/ML
SCDC · 323975 -
Dexamethasone / tobramycin Ophthalmic Suspension
SCDF · 378984 -
Dexamethasone / tobramycin Ophthalmic Product
SCDG · 1154524
Brand-Name Concepts
-
Dexamethasone 1 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension [Tobradex]
SBD · 208813 -
Dexamethasone 1 MG/ML / tobramycin 3 MG/ML [Tobradex]
SBDC · 569462 -
Dexamethasone / tobramycin Ophthalmic Suspension [Tobradex]
SBDF · 94334 -
Tobradex Ophthalmic Product
SBDG · 1179099 -
Tobradex
BN · 220330
📦 FDA Products & Package NDCs
24 products · 32 package NDCs
32 package NDCs map to RxCUI 309683 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00574-4031-05 | 1 BOTTLE, PLASTIC in 1 CARTON (0574-4031-05) / 5 mL in 1 BO... | TOBRAMYCIN AND DEXAMETHASONE | Padagis US LLC | 2022-03-17 |
| 00574-4031-10 | 1 BOTTLE, PLASTIC in 1 CARTON (0574-4031-10) / 10 mL in 1 B... | TOBRAMYCIN AND DEXAMETHASONE | Padagis US LLC | 2022-03-17 |
| 00574-4031-25 | 1 BOTTLE, PLASTIC in 1 CARTON (0574-4031-25) / 2.5 mL in 1... | TOBRAMYCIN AND DEXAMETHASONE | Padagis US LLC | 2022-03-17 |
| 24208-0295-05 | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BO... | Tobramycin and Dexamethasone | Bausch & Lomb Incorporated | 1999-10-27 |
| 24208-0295-10 | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 B... | Tobramycin and Dexamethasone | Bausch & Lomb Incorporated | 1999-10-27 |
| 24208-0295-25 | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1... | Tobramycin and Dexamethasone | Bausch & Lomb Incorporated | 1999-10-27 |
| 50090-1135-00 | 2.5 mL in 1 BOTTLE (50090-1135-0) | Tobramycin and Dexamethasone | A-S Medication Solutions | 2014-11-28 |
| 50090-1136-00 | 5 mL in 1 BOTTLE (50090-1136-0) | Tobramycin and Dexamethasone | A-S Medication Solutions | 2014-11-28 |
| 50090-1914-00 | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1... | Tobramycin and Dexamethasone | A-S Medication Solutions | 2015-07-02 |
| 50090-7267-00 | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) | TOBRAMYCIN AND DEXAMETHASONE | A-S Medication Solutions | 2024-10-07 |
| 61314-0647-05 | 1 BOTTLE in 1 CARTON (61314-647-05) / 5 mL in 1 BOTTLE | Tobramycin and Dexamethasone | Sandoz Inc | 2015-01-02 |
| 61314-0647-10 | 1 BOTTLE in 1 CARTON (61314-647-10) / 10 mL in 1 BOTTLE | Tobramycin and Dexamethasone | Sandoz Inc | 2009-01-02 |
| 61314-0647-25 | 1 BOTTLE in 1 CARTON (61314-647-25) / 2.5 mL in 1 BOTTLE | Tobramycin and Dexamethasone | Sandoz Inc | 2009-01-02 |
| 63629-9570-01 | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) | TOBRAMYCIN AND DEXAMETHASONE | Bryant Ranch Prepack | 2022-12-21 |
| 63629-9571-01 | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) | TOBRAMYCIN AND DEXAMETHASONE | Bryant Ranch Prepack | 2022-12-21 |
| 63629-9572-01 | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) | TOBRAMYCIN AND DEXAMETHASONE | Bryant Ranch Prepack | 2022-12-21 |
| 67296-2174-05 | 5 mL in 1 BOTTLE, PLASTIC (67296-2174-5) | TOBRAMYCIN AND DEXAMETHASONE | Redpharm Drug | 2022-03-17 |
| 68071-1821-02 | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1... | Tobramycin and Dexamethasone | NuCare Pharmaceuticals,Inc. | 2020-12-30 |
| 68071-2418-02 | 1 BOTTLE, DROPPER in 1 CARTON (68071-2418-2) / 2.5 mL in 1... | Tobramycin and Dexamethasone | NuCare Pharmaceuticals,Inc. | 2021-05-26 |
| 68071-4203-05 | 5 mL in 1 BOX (68071-4203-5) | Tobramycin and Dexamethasone | NuCare Pharmaceuticals,Inc. | 2017-12-28 |
| 68788-4081-05 | 1 BOTTLE in 1 CARTON (68788-4081-5) / 5 mL in 1 BOTTLE | Tobramycin and Dexamethasone | Preferred Pharmaceuticals Inc. | 2026-02-26 |
| 70518-3994-00 | 5 mL in 1 BOTTLE (70518-3994-0) | Tobramycin and Dexamethasone | REMEDYREPACK INC. | 2024-01-24 |
| 71335-2840-01 | 5 mL in 1 BOTTLE, PLASTIC (71335-2840-1) | TOBRAMYCIN AND DEXAMETHASONE | Bryant Ranch Prepack | 2025-10-21 |
| 71335-2854-01 | 2.5 mL in 1 BOTTLE, PLASTIC (71335-2854-1) | TOBRAMYCIN AND DEXAMETHASONE | Bryant Ranch Prepack | 2025-10-21 |
| 71335-2891-01 | 10 mL in 1 BOTTLE, PLASTIC (71335-2891-1) | TOBRAMYCIN AND DEXAMETHASONE | Bryant Ranch Prepack | 2025-10-21 |
| 72162-1128-02 | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) | TOBRAMYCIN AND DEXAMETHASONE | Bryant Ranch Prepack | 2024-12-24 |
| 72162-1128-04 | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) | TOBRAMYCIN AND DEXAMETHASONE | Bryant Ranch Prepack | 2024-12-24 |
| 72162-1128-07 | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) | TOBRAMYCIN AND DEXAMETHASONE | Bryant Ranch Prepack | 2024-12-24 |
| 80425-0260-01 | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) | Tobramycin and dexamethasone | Advanced Rx Pharmacy of Tennessee, LLC | 2023-02-15 |
| 80425-0366-01 | 5 mL in 1 BOTTLE (80425-0366-1) | Tobramycin and Dexamethasone | Advanced Rx of Tennessee, LLC | 2023-11-02 |
| 85766-0188-05 | 1 BOTTLE, DROPPER in 1 CARTON (85766-188-05) / 5 mL in 1 BO... | Tobramycin and Dexamethasone | Sportpharm LLC | 2026-03-20 |
| 85766-0188-10 | 1 BOTTLE, DROPPER in 1 CARTON (85766-188-10) / 10 mL in 1 B... | Tobramycin and Dexamethasone | Sportpharm LLC | 2026-07-02 |
Observed labelers:
Bryant Ranch Prepack (9) ·
A-S Medication Solutions (4) ·
Bausch & Lomb Incorporated (3) ·
NuCare Pharmaceuticals,Inc. (3) ·
Padagis US LLC (3) ·
Sandoz Inc (3)
· +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$4.9643
Range $4.2803–$5.1316
· middle 50% $4.2803–$5.1316
· 9 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.